SEHK:2507
SEHK:2507Aerospace & Defense

How Investors May Respond To Cirrus Aircraft (SEHK:2507) Expanding Always-On Connectivity In Its G7+ SR Series

In early January 2026, Cirrus Aircraft announced its 2026 SR Series G7+ models for the SR20, SR22 and SR22T, adding upgraded avionics, expanded global connectivity, new propeller options and refreshed designs across its best-selling single-engine piston lineup. A particularly distinctive element of the launch is Cirrus Global Connect’s expanded always-on weather and communication capabilities, which deepen integration between cockpit technology and continuous global connectivity for pilots...
SEHK:142
SEHK:142Food

Did First Pacific's 1-for-86.95652 Stock Split Just Shift Its (SEHK:142) Investment Narrative?

First Pacific Company Limited has already completed a substantial stock split or significant stock dividend, with a ratio of 1 to 86.95652, effective 16 December 2025. This unusually large split reshapes the company’s share count and trading dynamics, which can influence how investors assess liquidity and accessibility. Next, we’ll examine how this very large stock split interacts with First Pacific’s existing investment narrative around capital management and growth. Rare earth metals are...
SEHK:3696
SEHK:3696Life Sciences

Assessing InSilico Medicine Cayman TopCo (SEHK:3696) Valuation After A Sharp Recent Share Price Move

InSilico Medicine Cayman TopCo (SEHK:3696) has drawn attention after a sharp 43.09% move over the past week, prompting investors to reassess how its AI driven drug discovery model lines up with its current valuation. See our latest analysis for InSilico Medicine Cayman TopCo. The recent 7 day share price return of 43.09%, on top of a year to date share price return of 54.20% and a latest close of HK$57.95, points to momentum building around InSilico Medicine Cayman TopCo as investors reassess...
SEHK:2007
SEHK:2007Real Estate

Country Garden Holdings (SEHK:2007) Valuation Check After December 2025 Sales Update

December sales update and why it matters for shareholders Country Garden Holdings (SEHK:2007) has released preliminary unaudited sales figures for December 2025, reporting contracted sales attributable to shareholders of about RMB 2.69b and contracted sales gross floor area of roughly 0.31 million square meters. For investors tracking this China focused developer, these monthly numbers provide another reference point alongside the company’s recent share price performance, multi year total...
SEHK:1177
SEHK:1177Pharmaceuticals

Sino Biopharmaceutical (SEHK:1177) Is Up 5.0% After Advancing ROCK2 Drug TDI01 To Phase III - Has The Bull Case Changed?

Sino Biopharmaceutical’s board previously reported enrollment of the first patient in a global first Phase III trial of TDI01, a highly selective ROCK2 inhibitor for idiopathic pulmonary fibrosis, following encouraging Phase II efficacy and safety data. The same molecule has also entered Breakthrough Therapy Designation review in China for chronic graft-versus-host disease, underlining its potential relevance across multiple serious immune-related conditions. We’ll now examine how advancing...
SEHK:2333
SEHK:2333Auto

How Investors Are Reacting To Great Wall Motor (SEHK:2333) Mixed December Vs Strong Full-Year Sales Figures

Great Wall Motor Company Limited has released unaudited December 2025 figures, showing monthly sales of 124,020 units and production of 116,812 units, both lower than the same month a year earlier, while full-year sales rose to 1,323,672 units and production to 1,311,329 units. The contrast between weaker December volumes and higher full-year totals gives investors fresh insight into the company’s recent demand and output momentum. We’ll now examine how the softer December sales alongside...
SEHK:3690
SEHK:3690Hospitality

Meituan (SEHK:3690) Valuation Check After Recent Modest Share Price Momentum And 19.1% Undervaluation Estimate

Meituan (SEHK:3690) remains in focus for investors who are watching how its recent share performance lines up with the company’s current fundamentals, including revenue, earnings, and return figures over different time frames. See our latest analysis for Meituan. At a share price of HK$104.9, Meituan’s recent 30 day and 90 day share price returns of 2.44% and 5.00% suggest modest positive momentum. However, the 1 year total shareholder return of a 27.30% decline points to a weaker longer term...